6.1 High-Yield Recap by Domain

Why a Cross-Domain Recap Matters

The Certified Gastroenterology Registered Nurse (CGRN) exam, administered by the American Board of Certification for Gastroenterology Nurses (ABCGN) through Prometric, delivers 175 multiple-choice items in 4 hours. Of those, 150 are scored and 25 are unscored pretest items. The exam rarely tests one isolated fact; most vignettes blend assessment, procedure care, intervention, and infection control into a single patient story. A high-yield recap that connects domains is far more useful in the final week than rereading any single chapter.

The four official ABCGN domains and their scored weights anchor your review:

Gastroenterological Procedures is the single largest domain. When study time is short, weight your review toward procedure care and complication recognition first, then layer in the supporting domains.

Must-Know by Domain

Use this table as a final-pass checklist. Each row is one high-yield anchor you should recall without notes.

Sedation and Reversal Agents

Procedural moderate sedation is heavily tested. Know each agent, its role, and the reversal drug with a starting dose.

• Midazolam — a benzodiazepine for sedation and anxiolysis; produces amnesia and respiratory depression. Typical adult titration is 0.5-1 mg increments.
• Fentanyl and meperidine — opioids for analgesia; additive respiratory depression when combined with benzodiazepines.
• Propofol — a sedative-hypnotic with a narrow margin and NO reversal agent, so airway readiness is mandatory; in most settings it is administered by anesthesia.
• Flumazenil — reverses benzodiazepines, 0.2 mg IV initial, repeated at 1-minute intervals to about a 1 mg total; precipitates seizures in chronic benzodiazepine users.
• Naloxone — reverses opioids, 0.04-0.4 mg IV titrated to respiration; re-sedation is common because naloxone is shorter-acting than most opioids.

The exam expects you to know that a benzodiazepine plus an opioid depresses respiration synergistically, and that supplemental oxygen, jaw-thrust, and bag-valve-mask support precede any pharmacologic reversal.

Reprocessing, Spaulding, and Quality Metrics

The Spaulding classification sorts devices by infection risk and dictates the required level of decontamination.

Flexible GI endoscopes are semicritical and require HLD after thorough manual cleaning. Accessories that breach mucosa or enter the bloodstream are critical and must be sterilized or single-use disposable. HLD is commonly achieved with glutaraldehyde, ortho-phthalaldehyde (OPA), or peracetic acid in an automated endoscope reprocessor (AER).

Reprocessing sequence (memorize the order): bedside precleaning -> leak test -> manual cleaning with enzymatic detergent and channel brushing -> HLD or sterilization -> rinse -> 70-90% alcohol flush and forced-air dry -> hang vertically in a ventilated cabinet. Precleaning before debris dries is the single most time-critical step because dried bioburden and biofilm resist HLD.

Colonoscopy Quality Metrics

GI quality items cluster around colonoscopy benchmarks and safety indicators. The 2024 ACG/ASGE Task Force raised several targets, so learn the current numbers:

• Adenoma detection rate (ADR) — the key colonoscopy quality measure; the 2024 minimum benchmark is >=35% overall (>=40% in men, >=30% in women) using the broadened definition that includes screening, surveillance, and diagnostic exams in patients 45 and older. Each ~1% rise in ADR is associated with roughly a 3% lower interval colorectal cancer risk.
• Sessile serrated lesion detection rate (SSLDR) — a newly added 2024 indicator with a >=6% target.
• Cecal intubation rate — documents a complete colon examination; target >=95%.
• Withdrawal time — a minimum mean of >=8 minutes on negative screening exams (raised from the older >=6-minute target) supports adequate mucosal inspection.
• Bowel preparation adequacy — at least 90% of exams should have adequate prep; inadequate prep lowers detection and may force an earlier repeat exam, often within one year.

Core GI Pharmacology

Beyond sedation, the exam tests medications used during and around GI procedures.

• Simethicone — an antifoaming agent that reduces intraluminal bubbles to improve mucosal visualization; increasingly added to bowel preps.
• Glucagon — relaxes GI smooth muscle to reduce spasm during ERCP or difficult intubation; use caution in pheochromocytoma and insulinoma, and watch for rebound hyperglycemia.
• Polyethylene glycol (PEG) and other osmotic preps — bowel cleansing; monitor for fluid and electrolyte shifts, especially in older or renally impaired patients. Sodium phosphate preps risk acute phosphate nephropathy and are avoided in renal impairment.
• Proton pump inhibitors (PPIs) and H2-receptor antagonists — acid suppression for gastroesophageal reflux disease (GERD) and peptic ulcer disease.
• Octreotide — reduces splanchnic blood flow in acute variceal bleeding; often paired with band ligation.
• Epinephrine injection — endoscopic hemostasis for bleeding lesions; combined with thermal or mechanical (clip) therapy.

Tie pharmacology back to nursing assessment: review anticoagulant and antiplatelet status before biopsy or polypectomy, verify iodinated-contrast allergy before ERCP, and monitor electrolytes with aggressive bowel preps. A common trap is assuming a held anticoagulant needs no follow-up planning — the nurse confirms the bridging and resumption plan with the provider.